Aldeyra Therapeutics, Inc.

FIRST MANHATTAN CO. LLC. ALDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

34,745

Value ($000)

180

Weight

0.0%

2020 Q2 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	180	0.0%	34,745	12/31/2025
2025 Q3	11/14/2025	181	0.0%	34,745	9/30/2025
2025 Q2	8/14/2025	133	0.0%	34,745	6/30/2025
2025 Q1	5/15/2025	200	0.0%	34,745	3/31/2025
2024 Q4	2/14/2025	173	0.0%	34,745	12/31/2024
2024 Q3	11/14/2024	187	0.0%	34,745	9/30/2024
2024 Q2	8/15/2024	115	0.0%	34,745	6/30/2024
2024 Q1	5/15/2024	114	0.0%	34,745	3/31/2024
2023 Q4	2/13/2024	122	0.0%	34,745	12/31/2023
2023 Q3	11/14/2023	232	0.0%	34,745	9/30/2023
2023 Q2	8/14/2023	292	0.0%	34,745	6/30/2023
2023 Q1	5/15/2023	345	0.0%	34,745	3/31/2023
2022 Q4	2/14/2023	242	0.0%	34,745	12/31/2022
2022 Q3	11/14/2022	185	0.0%	34,745	9/30/2022
2022 Q2	8/15/2022	138	0.0%	34,745	6/30/2022
2022 Q1	5/16/2022	154	0.0%	34,745	3/31/2022
2021 Q4	2/14/2022	138	0.0%	34,745	12/31/2021
2021 Q3	11/15/2021	305	0.0%	34,745	9/30/2021
2021 Q2	8/16/2021	405	0.0%	35,746	6/30/2021
2020 Q2	8/14/2020	1	0.0%	350	6/30/2020